US Patent 9415121 Delivery of MECP2 polynucleotide using recombinant AAV9
Patent 9415121 was granted and assigned to Nationwide Children's Hospital on August, 2016 by the United States Patent and Trademark Office.
Is a
Date Filed
March 14, 2013
Date of Patent
August 16, 2016
Patent Application Number
13830515
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9415121 Delivery of MECP2 polynucleotide using recombinant AAV9
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
